Research chemicals for laboratory use only
Reserve Research sells peptides and research compounds strictly for in-vitro research use only. You must be 21 years of age or older and a qualified researcher to proceed.
By entering, you confirm you are purchasing for legitimate research purposes only. These products are not intended for human or veterinary use, diagnosis, or treatment.
Tirzepatide is a synthetic dual-receptor agonist peptide that binds two incretin receptors at once — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Both receptors are widely studied in in-vitro metabolic and endocrine research, making this compound a useful reference tool for receptor-signaling studies.
In preclinical laboratory models, tirzepatide has been examined for receptor-binding affinity, downstream cAMP and insulinotropic signaling, and comparative agonist activity. Because it targets both the GIP and GLP-1 pathways simultaneously, it offers a model for characterizing how dual-receptor activation differs from single-receptor approaches.
This vial contains lyophilized Tirzepatide at high purity, verified by independent, third-party analytical testing.
Structure, CAS and molecular data, receptor pharmacology, storage and published literature: see our Tirzepatide research reference.
Price range: $85.00 through $130.00
| Molecular Weight | 4813.5 Da |
|---|---|
| Molecular Formula | C225H348N48O68 |
| Sequence | Y-Aib-E-G-T-F-T-S-D-Y-S-I-Aib-L-D-K-I-A-Q-K*-A-F-V-Q-W-L-I-A-G-G-P-S-S-G-A-P-P-P-S-NH₂ (39 aa; K* = Lys20 acylated with C20 diacid via γGlu-2×AEEA) |
| CAS Number | 2023788-19-2 |
| Appearance | White to off-white lyophilized powder |
| Storage | -20°C / -4°F (lyophilized); 4°C / 39°F reconstituted in Bacteriostatic Water, use within 28 days |
| Solubility | Soluble in water at 1 mg/mL |
| Size | 10mg, 30mg |
|---|
Research Summary: The following information is provided for research context only.
Tirzepatide is a synthetic dual-receptor agonist peptide that binds two incretin receptors at once — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Both receptors are widely studied in in-vitro metabolic and endocrine research, making this compound a useful reference tool for receptor-signaling studies.
In preclinical laboratory models, tirzepatide has been examined for receptor-binding affinity, downstream cAMP and insulinotropic signaling, and comparative agonist activity. Because it targets both the GIP and GLP-1 pathways simultaneously, it offers a model for characterizing how dual-receptor activation differs from single-receptor approaches.
This vial contains lyophilized Tirzepatide at high purity, verified by independent, third-party analytical testing.
Structure, CAS and molecular data, receptor pharmacology, storage and published literature: see our Tirzepatide research reference.
Sale!
Research-grade Semaglutide — GLP-1 receptor agonist analogue, lyophilized, high purity. Independently third-party tested with COA included. For research…
Research-grade KPV — Lys-Pro-Val tripeptide, C-terminal fragment of α-MSH, lyophilized, high purity. Independently third-party tested with COA included.…
Research-grade Semax — synthetic ACTH-derived heptapeptide, lyophilized, high purity. Independently third-party tested with COA included. For research use…
Research-grade TB-500 — synthetic thymosin beta-4 fragment, lyophilized, high purity. Independently third-party tested with COA included. For research…
Reviews
There are no reviews yet.